|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Conte I, Banfi S and Bovolenta P:
Non-coding RNAs in the development of sensory organs and related
diseases. Cell Mol Life Sci. 70:4141–4155. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weber JA, Baxter DH, Zhang S, Huang DY,
Huang KH, Lee MJ, Galas DJ and Wang K: The microRNA spectrum in 12
body fluids. Clin Chem. 56:1733–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boutros PC, Lau SK, Pintilie M, Liu N,
Shepherd FA, Der SD, Tsao MS, Penn LZ and Jurisica I: Prognostic
gene signatures for non-small-cell lung cancer. Proc Natl Acad Sci
USA. 106:2824–2828. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roepman P, Jassem J, Smit EF, Muley T,
Niklinski J, van de Velde T, Witteveen AT, Rzyman W, Floore A,
Burgers S, et al: An immune response enriched 72-gene prognostic
profile for early-stage non-small-cell lung cancer. Clin Cancer
Res. 15:284–290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen X, Guan X, Zhang H, Xie X, Wang H,
Long J, Cai T, Li S, Liu Z and Zhang Y: DAL-1 attenuates
epithelial-to mesenchymal transition in lung cancer. J Exp Clin
Cancer Res. 34:32015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liang H, Yan X, Pan Y, Wang Y, Wang N, Li
L, Liu Y, Chen X, Zhang CY, Gu H, et al: MicroRNA-223 delivered by
platelet-derived microvesicles promotes lung cancer cell invasion
via targeting tumor suppressor EPB41L3. Mol Cancer. 14:582015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai T, Guan X, Wang H, Fang Y, Long J, Xie
X, et al: miR-26a regulates ANXA1, rather than DAL-1, in the
development of lung cancer. Oncol Lett (accepted).
|
|
11
|
Lin J, Zhang L, Huang H, Huang Y, Huang L,
Wang J, Huang S, He L, Zhou Y, Jia W, et al: miR-26b/KPNA2 axis
inhibits epithelial ovarian carcinoma proliferation and metastasis
through downregulating OCT4. Oncotarget. 6:23793–23806. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen G, Lin Y, Yang X, Zhang J, Xu Z and
Jia H: MicroRNA-26b inhibits epithelial-mesenchymal transition in
hepatocellular carcinoma by targeting USP9X. BMC Cancer.
14:3932014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang C, Tong J and Huang G: Nicotinamide
phosphoribosyl transferase (Nampt) is a target of microRNA-26b in
colorectal cancer cells. PLoS One. 8:e699632013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pierce ML, Weston MD, Fritzsch B, Gabel
HW, Ruvkun G and Soukup GA: MicroRNA-183 family conservation and
ciliated neurosensory organ expression. Evol Dev. 10:106–113. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuhn S, Johnson SL, Furness DN, Chen J,
Ingham N, Hilton JM, Steffes G, Lewis MA, Zampini V, Hackney CM, et
al: miR-96 regulates the progression of differentiation in
mammalian cochlear inner and outer hair cells. Proc Natl Acad Sci
USA. 108:2355–2360. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo Y, Liu H, Zhang H, Shang C and Song Y:
miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer.
Oncol Lett. 4:561–565. 2012.PubMed/NCBI
|
|
17
|
Yu N, Fu S, Liu Y, Xu Z, Liu Y, Hao J,
Wang B and Zhang A: miR-96 suppresses renal cell carcinoma invasion
via downregulation of Ezrin expression. J Exp Clin Cancer Res.
34:1072015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li C, Du X, Tai S, Zhong X, Wang Z, Hu Z,
Zhang L, Kang P, Ji D, Jiang X, et al: GPC1 regulated by miR-96-5p,
rather than miR-182-5p, in inhibition of pancreatic carcinoma cell
proliferation. Int J Mol Sci. 15:6314–6327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma L, Huang Y, Zhu W, Zhou S, Zhou J, Zeng
F, Liu X, Zhang Y and Yu J: An integrated analysis of miRNA and
mRNA expressions in non-small cell lung cancers. PLoS One.
6:e265022011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo H, Li Q, Li W, Zheng T, Zhao S and Liu
Z: miR-96 downregulates RECK to promote growth and motility of
non-small cell lung cancer cells. Mol Cell Biochem. 390:155–160.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu Z, Liu K, Wang Y, Xu Z, Meng J and Gu
S: Upregulation of microRNA-96 and its oncogenic functions by
targeting CDKN1A in bladder cancer. Cancer Cell Int. 15:1072015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fendler A, Jung M, Stephan C, Erbersdobler
A, Jung K and Yousef GM: The antiapoptotic function of miR-96 in
prostate cancer by inhibition of FOXO1. PLoS One. 8:e808072013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin H, Dai T, Xiong H, Zhao X, Chen X, Yu
C, Li J, Wang X and Song L: Unregulated miR-96 induces cell
proliferation in human breast cancer by downregulating
transcriptional factor FOXO3a. PLoS One. 5:e157972010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song HM, Luo Y, Li D-F, Wei CK, Hua KY,
Song JL, Xu H, Maskey N and Fang L: MicroRNA-96 plays an oncogenic
role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in
papillary thyroid carcinoma cells. Int J Clin Exp Pathol.
8:9889–9900. 2015.PubMed/NCBI
|
|
25
|
Gao F and Wang W: MicroRNA-96 promotes the
proliferation of colorectal cancer cells and targets tumor protein
p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1)
and FOXO3a. Mol Med Rep. 11:1200–1206. 2015.PubMed/NCBI
|
|
26
|
Zhang J, Kong X, Li J, Luo Q, Li X, Shen
L, Chen L and Fang L: miR-96 promotes tumor proliferation and
invasion by targeting RECK in breast cancer. Oncol Rep.
31:1357–1363. 2014.PubMed/NCBI
|
|
27
|
Xu L, Zhong J, Guo B, Zhu Q, Liang H, Wen
N, Yun W and Zhang L: miR-96 promotes the growth of prostate
carcinoma cells by suppressing MTSS1. Tumour Biol. 37:12023–12032.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Feng J, Yu J, Pan X, Li Z, Chen Z, Zhang
W, Wang B, Yang L, Xu H, Zhang G, et al: HERG1 functions as an
oncogene in pancreatic cancer and is downregulated by miR-96.
Oncotarget. 5:5832–5844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang X, Lv W, Zhang JH and Lu DL: miR 96
functions as a tumor suppressor gene by targeting NUAK1 in
pancreatic cancer. Int J Mol Med. 34:1599–1605. 2014.PubMed/NCBI
|
|
30
|
Shen J, Liu Z, Todd NW, Zhang H, Liao J,
Yu L, Guarnera MA, Li R, Cai L, Zhan M, et al: Diagnosis of lung
cancer in individuals with solitary pulmonary nodules by plasma
microRNA biomarkers. BMC Cancer. 11:3742011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu W, Liu X, He J, Chen D, Hunag Y and
Zhang YK: Overexpression of members of the microRNA-183 family is a
risk factor for lung cancer: A case control study. BMC Cancer.
11:3932011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ebrahimi S, Hosseini M, Ghasemi F,
Shahidsales S, Maftouh M, Akbarzade H, Parizadeh SA, Hassanian SM
and Avan A: Circulating microRNAs as potential diagnostic,
prognostic and therapeutic targets in pancreatic cancer. Curr Pharm
Des. 22:6444–6450. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leung WK, He M, Chan AW, Law PT and Wong
N: Wnt/β-catenin activates miR-183/96/182 expression in
hepatocellular carcinoma that promotes cell invasion. Cancer Lett.
362:97–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun Y, Liu Y, Cogdell D, Calin GA, Sun B,
Kopetz S, Hamilton SR and Zhang W: Examining plasma microRNA
markers for colorectal cancer at different stages. Oncotarget.
7:11434–11449. 2016.PubMed/NCBI
|
|
35
|
Kobayashi S, Boggon TJ, Dayaram T, Jänne
PA, Kocher O, Meyerson M, Johnson BE, Eck MJ, Tenen DG and Halmos
B: EGFR mutation and resistance of non-small-cell lung cancer to
gefitinib. N Engl J Med. 352:786–792. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang C, Ma R, Xu Y, Li N, Li Z, Yue J, Li
H, Guo Y and Qi D: Wnt2 promotes non-small cell lung cancer
progression by activating WNT/β-catenin pathway. Am J Cancer Res.
5:1032–1046. 2015.PubMed/NCBI
|
|
37
|
Chen X, Song X, Yue W, Chen D, Yu J, Yao Z
and Zhang L: Fibulin-5 inhibits Wnt/β-catenin signaling in lung
cancer. Oncotarget. 6:15022–15034. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lu C, Huang T, Chen W and Lu H: GnRH
participates in the self-renewal of A549-derived lung cancer
stem-like cells through upregulation of the JNK signaling pathway.
Oncol Rep. 34:244–250. 2015.PubMed/NCBI
|
|
39
|
Scagliotti GV and Novello S: The role of
the insulin-like growth factor signaling pathway in non-small cell
lung cancer and other solid tumors. Cancer Treat Rev. 38:292–302.
2012. View Article : Google Scholar : PubMed/NCBI
|
